Jason Gardner, Flagship CEO-Partner and CEO of Ampersand Biomedicines shares how Ampersand is programming medicines to act only where needed. More from Flagship @ JPM2024 here.
Related Companies
- Ampersand Biomedicines Founded: 2021
More from:
Human Health
